01OverviewDefinition, clinical context and the essential points that orientate the chapter.
A late fluid-filled space after pancreatitis is not automatically a pseudocyst. The name should convey whether necrosis is present and whether a mature wall has formed. These features determine how a collection can be approached and whether drainage alone is likely to empty it. A seemingly simple space may contain substantial debris on MRI or endoscopic ultrasound, while an incidental pancreatic cyst may have a neoplastic cause and require a different assessment altogether.
The first clinical question is what problem the collection is causing. Many uncomplicated collections regress or remain clinically harmless under observation. Others prevent eating, obstruct the stomach or bile duct, become infected, bleed or reflect ongoing leakage from the pancreatic duct. Specialist treatment addresses that problem and the underlying anatomy. Successful drainage is measured by recovery of function and control of complications, followed by a safe device and duct plan, rather than by an impressive reduction in scan diameter alone.
Key points
- A pseudocyst is predominantly fluid within a defined inflammatory wall, with essentially no solid necrotic debris.
- Walled-off necrosis contains non-viable tissue as well as fluid within an organised wall; it can appear deceptively homogeneous on CT.
- Before a wall forms, distinguish early fluid-only from necrotic collections. Maturation commonly takes about four weeks, but neither that interval nor size alone determines intervention; symptoms, complications and safe anatomy do.
- Four weeks is a usual maturation interval, not a substitute for examining the actual wall or a mandatory waiting period in a deteriorating patient.
- Drainage decisions follow infection, symptoms, obstruction and other complications; a diameter threshold alone is insufficient.
- Characterise the duct and vessels when relevant, and give every inserted drain or stent an explicit review and removal or exchange plan.
02AetiologyUnderlying causes, associations and risk factors, with why each one matters.
After interstitial inflammation
Leakage of pancreatic secretions and inflammatory fluid may produce an early peripancreatic fluid collection. When a fluid-rich collection persists and develops an organised inflammatory boundary, the mature lesion may be described as a pseudocyst.
After tissue necrosis
Necrotizing injury produces a mixture of fluid and non-viable pancreatic or peripancreatic tissue. Organisation of this material creates walled-off necrosis; continuing secretion from a damaged or disconnected duct can contribute to persistence or recurrence.
03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.
- 1Inflammatory wall formation
A pseudocyst is surrounded by inflammatory and fibrous tissue rather than a true epithelial lining. Its mature boundary distinguishes it from an early unencapsulated fluid collection and may provide an interface suitable for internal drainage.
- 2Solid material within a cavity
Liquefaction of necrotic tissue is incomplete and variable. A collection may contain dependent debris or loculated solid material despite a predominantly fluid appearance, explaining why emptying the liquid does not always achieve adequate treatment.
- 3Pressure and duct continuity
A collection can compress the stomach, duodenum, bile duct or vessels. At the same time, an ongoing duct communication can continue to deliver secretions into the space, linking local mass effects with the risk of recurrence.
04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.
Ask about early satiety, vomiting, pain, fever, weight change and the ability to eat a normal meal. Relate the timing to the original attack and establish whether that episode was interstitial or necrotizing. A patient may look comfortable while consuming too little to maintain weight; document intake rather than relying on the absence of severe pain.
Gastric compression can produce persistent vomiting and nutritional failure; biliary compression may cause jaundice. Infection is judged from clinical deterioration and appropriate imaging or microbiology. Bleeding may be internal before external signs appear. These findings change urgency and may require radiological or surgical assessment before an endoscopic drainage procedure is attempted.
05InvestigationsWhat to request, why it matters and how to interpret it.
Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.
- 01
Contrast-enhanced CT anatomyFirst step - Why
- Define the collection, surrounding organs, necrosis and important vascular relationships.
- Interpretation and limitations
- Interpret contents and wall separately. An early homogeneous collection without a wall after interstitial pancreatitis is an acute peripancreatic fluid collection; an early collection containing necrosis is an acute necrotic collection. A mature fluid-only space supports pseudocyst, while an organised space containing necrotic debris supports walled-off necrosis.
- 02
MRI and MRCP - Why
- Resolve uncertain solid debris and assess duct continuity or communication.
- Interpretation and limitations
- MRI may show debris missed on CT and change a presumed pseudocyst into walled-off necrosis. MRCP can help identify a disrupted or disconnected duct that will affect recurrence and the duration or type of drainage. A scan finding must still be matched to the patient’s symptoms and the proposed intervention.
- 03
Endoscopic ultrasound assessment - Why
- Characterise the collection and assess an intended internal drainage route.
- Interpretation and limitations
- EUS assesses solid contents, the distance to the gut and intervening vessels; it can also evaluate an alternative cyst diagnosis. The availability of an apparent route does not itself justify drainage. A suspected pseudoaneurysm needs appropriate vascular assessment and control, with interventional radiology involved before puncturing the collection.
- 04
Clinical and biochemical reassessment - Why
- Identify infection, impaired nutrition, biliary obstruction or bleeding.
- Interpretation and limitations
- Use serial observations, blood count, renal and liver profiles, inflammatory markers and nutritional assessment according to the presentation. Falling haemoglobin or new cholestasis requires explanation. Serum amylase does not reliably establish collection type or the need for a procedure, and an isolated raised inflammatory marker is not proof of infected necrosis.
06Differential diagnosisRealistic alternatives and the features that help distinguish them.
Acute peripancreatic fluid collection
This early fluid-only collection follows interstitial oedematous pancreatitis and lacks a mature wall. It often resolves during recovery and should not be relabelled as a pseudocyst solely because its measured diameter is large.
Acute necrotic collection
An early mixture of fluid and necrotic material lacks complete encapsulation. Its contents resemble those of later walled-off necrosis, but the absent mature boundary changes the feasibility and risks of drainage.
Cystic neoplasm or vascular lesion
A pancreatic cystic tumour can coexist with, or provoke, pancreatitis. A pseudoaneurysm may resemble a cystic space and can cause serious bleeding if punctured, making careful imaging review essential before an invasive approach.
Additional chapter-specific clues
A pseudocyst has a mature inflammatory wall and essentially liquid contents. A walled-off necrotic collection includes dead pancreatic or surrounding tissue. Both may develop weeks after an attack, so elapsed time cannot distinguish them. The report should state the wall, solid material, location and relationship to nearby structures instead of simply describing a cyst.
Reconsider the presumed inflammatory origin when there is no convincing pancreatitis history, a mural nodule, an unusual cyst pattern or a discordant course. Pancreatitis itself can accompany a neoplasm, so its occurrence does not settle the diagnosis. Review prior imaging and obtain specialist pancreatic imaging and tissue or fluid assessment only when it will resolve an important uncertainty.
07ManagementImmediate care, first-line treatment, alternatives and escalation.
01Worked casePersistent vomiting after a necrotizing attackFirst stepA 51-year-old woman returns seven weeks after necrotizing pancreatitis with daily vomiting, early satiety and a 5 kg weight loss; CT calls an 8 cm retrogastric space a probable pseudocyst.+
- 1She is afebrile and haemodynamically stable, but cannot maintain oral nutrition. MRI shows a mature wall with extensive internal debris and compression of the stomach: this is walled-off necrosis. The indication for intervention is sustained gastric obstruction and nutritional failure, rather than the 8 cm diameter. The team provides enteral nutritional support while arranging pancreatic-centre assessment.
- 2EUS confirms a suitable internal route without an intervening vessel. The specialist team performs endoscopic drainage and records the stent type, responsible endoscopist and planned interval imaging and device review. Over the next 72 hours, vomiting stops and she tolerates increasing food intake; no immediate necrosectomy is required because she is improving.
- 3At the arranged follow-up she has regained 2 kg and imaging shows substantial collapse of the collection. The team reassesses duct anatomy and documents the subsequent stent removal or longer-term strategy according to that result. She receives clear instructions to return for bleeding, fever or recurrent vomiting, rather than assuming that symptom relief has completed all follow-up.
02Classify then decideA collection found on follow-up imagingA patient is referred with a scan report describing a pancreatic cyst after pancreatitis.+
- 1Confirm the original diagnosis, timing and current symptoms, then review the images for wall formation and solid debris. Use MRI or EUS where the answer would alter treatment, and reconsider a cystic neoplasm if the clinical or imaging history is atypical.
- 2Observe an uncomplicated collection when the patient is well and maintaining nutrition, with an individualised review plan. Do not make asymptomatic size alone an automatic drainage indication. In chronic pancreatitis, even an apparently asymptomatic pseudocyst needs specialist consideration if there is duct disruption or pressure on vessels or the diaphragm, or a significant risk of rupture or infection.
- 3For persistent pain, obstruction, nutritional failure or infection attributable to the collection, agree a treatment route in the pancreatic multidisciplinary team. Endoscopic treatment is appropriate when the anatomy permits; percutaneous and surgical approaches remain useful when internal drainage is unsuitable or insufficient.
03Treat and reviewA complication requires a procedureIntervention has been agreed after anatomy and physiological status have been assessed.+
- 1For a pseudocyst associated with chronic pancreatitis, NICE recommends EUS-guided drainage or selected transpapillary drainage for a head-of-pancreas location; discuss surgery if endoscopic treatment fails or is unsuitable. For infected necrosis, use a step-up approach and favour endoscopic drainage when feasible, with percutaneous access where appropriate.
- 2If the patient can safely wait, allow an immature necrotic collection to organise before intervention. Persistent sepsis despite treatment, organ deterioration or an urgent mechanical or vascular complication can override a calendar-based delay. A mature wall improves procedural options but does not eliminate bleeding, perforation or infection risks.
- 3After drainage, reassess symptoms, food intake, physiology and the need for repeat imaging. Residual debris alone does not mandate necrosectomy in a recovering patient. Investigate recurrent collections for duct disruption and retain ownership of every stent or drain until removal, exchange or a documented longer-term plan is completed.
08ComplicationsImportant consequences, why they occur and why they matter clinically.
Infection and systemic illness
Bacterial contamination of a collection can produce sepsis and organ dysfunction. Infection may develop after initial improvement, while sterile inflammation or an unrelated infection can mimic this presentation and require a different response.
Obstruction and malnutrition
Compression of adjacent gastrointestinal structures can limit intake or cause vomiting. Sustained nutritional impairment may become the principal clinical problem even in the absence of fever or marked pain.
Bleeding and recurrent fluid
Vascular involvement may cause haemorrhage into the collection or gastrointestinal tract. Separately, continuing duct leakage or disconnection can cause a cavity to recur after apparently successful drainage and requires an anatomical reassessment.
09Monitoring and follow-upTreatment response, safety checks and longer-term review.
- Track the symptom that prompted intervention: vomiting, pain, fever or inability to eat. A smaller collection without improved function should prompt reconsideration of residual obstruction, infection or another diagnosis.
- Review weight, dietary intake and evidence of exocrine insufficiency or diabetes after the pancreatitis episode. Nutritional recovery can lag behind radiological improvement and may require dietetic and enzyme assessment.
- After a procedure, assess promptly for new pain, fever, gastrointestinal bleeding or circulatory change. Ensure the patient knows which symptoms require urgent reassessment and who will arrange the next appointment.
- Record the location and type of each drain or stent, the responsible service and the planned imaging and device decision. Check completion of that plan; an undocumented retained device is not a follow-up strategy.
10Special situationsVariants, exceptions and circumstances that change the usual approach.
Time is a clue, contents are the discriminator
Both a pseudocyst and walled-off necrosis commonly have time to mature after about four weeks. What separates them is the presence of necrotic material. An exam stem that supplies debris is giving a more discriminating clue than a shared interval of six or eight weeks.
Drainage and debridement answer different problems
Draining liquid can relieve pressure and control infection while leaving solid necrosis behind. Some patients recover with drainage alone; others need subsequent removal of dead tissue. Agree the next step from clinical response and accessible anatomy instead of promising that every walled-off collection needs immediate necrosectomy.
The duct can sustain recurrence
A persistent duct leak or a disconnected upstream segment can refill a successfully drained cavity. Recurrent symptoms therefore require review of duct continuity and the intended drainage strategy. Treating the recurrent space without recognising the continuing secretion source may lead to repeated procedures with only temporary benefit.
A diameter is not a treatment plan
A collection’s size describes anatomy but does not establish benefit from intervention. A smaller space causing obstruction may need treatment while a larger uncomplicated space may be observed. Document the specific clinical indication and expected benefit so that procedural risk can be weighed against a meaningful outcome.
11Common pitfallsFrequent interpretation and management errors.
- 01
Using pseudocyst as a generic name for any collection after pancreatitis, including an early unencapsulated necrotic collection.
- 02
Reading a homogeneous CT appearance as proof that no solid debris is present when MRI or EUS would change the proposed procedure.
- 03
Applying an automatic six-centimetre drainage threshold or insisting on waiting four weeks despite uncontrolled deterioration.
- 04
Assuming every pancreatic cyst in a patient who has had pancreatitis is inflammatory, without considering neoplasia or a vascular mimic.
- 05
Discharging a patient after successful drainage without a named service and a documented stent or drain review plan.